The use of fibrinolytic therapy, the most widely applied reperfusion therapy, has been extensively investigated in almost 200,000 patients enrolled in randomized clinical trials (1-4). It is logistically ideal for widespread use at almost any medical facility. A few
From: Contemporary Cardiology: Management of Acute Coronary Syndromes, Second Edition Edited by: C. P. Cannon © Humana Press Inc., Totowa, NJ
key concepts, corroborated by angiographic evaluation and substantial clinical follow-up, have emerged from this vast experience.
Was this article helpful?